文献速递冠心病血脂与心血管预防

炎症相关代谢物标志物改善心肌梗死风险预测

Improvement of myocardial infarction risk prediction via inflammation-associated metabolite biomarkers.
PubMed 文献 · Heart · 2017-03-02

基于三个独立前瞻性队列共2257名基线无心肌梗死参与者,采用靶向代谢组学方法识别与 incident MI 相关的代谢物。鉴定出精氨酸和两种溶血磷脂酰胆碱(LPC 17:0 和 LPC 18:2)三种代谢物,在荟萃分析中显著,并在部分队列中提高 Framingham 风险评分的预测价值。这些代谢物减弱了 hsCRP 与 MI 的关联,提示与全身炎症的潜在联系。

要点

  • 在KORA S4队列中,140种代谢物中有16种与 incident MI 名义相关(p<0.05)。
  • 精氨酸、LPC 17:0 和 LPC 18:2 在包含三个研究的荟萃分析中显著(p<0.0003)。
  • 三种代谢物在KORA S4和AGES-REFINE中提高 Framingham 风险评分的AUC,但在KORA S2中未观察到。

核心结论

  • 鉴定出三种代谢物标志物,联合使用可提高 Framingham 风险评分的预测价值。
  • 这些三种代谢物减弱了 hsCRP 与 MI 的关联,提示与全身炎症的潜在联系。

研究设计与样本

  • 使用三个独立前瞻性队列(KORA S4、KORA S2 和 AGES-REFINE),共2257名基线无心肌梗死病史的参与者。
  • 采用靶向代谢组学方法识别与 incident MI 相关的代谢物,并评估其与 hsCRP 的关联。

主要发现

  • 在KORA S4队列中,140种代谢物中有16种与 incident MI 名义相关(p<0.05)。
  • 通过 backward stepwise selection 在KORA S4中选择精氨酸、LPC 17:0 和 LPC 18:2 三种代谢物作为生物标志物。
  • 在包含所有三个研究的荟萃分析中,这三种代谢物显著(p<0.0003)。
  • 这三种代谢物提高了 Framingham 风险评分的预测价值,在KORA S4中 AUC 从0.70升至0.78(p=0.001),在AGES-REFINE中从0.70升至0.76(p=0.02),但在KORA S2中未观察到。
  • 代谢物生物标志物减弱了 hsCRP 与 MI 的关联。

关键数值与推荐

  • KORA S4中16种代谢物与 incident MI 名义相关(p<0.05)。
  • 三种代谢物在荟萃分析中显著(p<0.0003)。
  • KORA S4中 AUC 从0.70升至0.78(p=0.001);AGES-REFINE中从0.70升至0.76(p=0.02);KORA S2中未观察到。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The comprehensive assaying of low-molecular-weight compounds, for example, metabolomics, provides a unique tool to uncover novel biomarkers and understand pathways underlying myocardial infarction (MI). We used a targeted metabolomics approach to identify biomarkers for MI and evaluate their involvement in the pathogenesis of MI. METHODS AND RESULTS: Using three independent, prospective cohorts (KORA S4, KORA S2 and AGES-REFINE), totalling 2257 participants without a history of MI at baseline, we identified metabolites associated with incident MI (266 cases). We also investigated the association between the metabolites and high-sensitivity C reactive protein (hsCRP) to understand the relation between these metabolites and systemic inflammation. Out of 140 metabolites, 16 were nominally associated (p<0.05) with incident MI in KORA S4. Three metabolites, arginine and two lysophosphatidylcholines (LPC 17:0 and LPC 18:2), were selected as biomarkers via a backward stepwise selection procedure in the KORA S4 and were significant (p<0.0003) in a meta-analysis comprising all three studies including KORA S2 and AGES-REFINE. Furthermore, these three metabolites increased the predictive value of the Framingham risk score, increasing the area under the receiver operating characteristic score in KORA S4 (from 0.70 to 0.78, p=0.001) and AGES-REFINE study (from 0.70 to 0.76, p=0.02), but was not observed in KORA S2. The metabolite biomarkers attenuated the association between hsCRP and MI, indicating a potential link to systemic inflammatory processes. CONCLUSIONS: We identified three metabolite biomarkers, which in combination increase the predictive value of the Framingham risk score. The attenuation of the hsCRP-MI association by these three metabolites indicates a potential link to systemic inflammation.

来源:Heart,查看原文。版权归原作者所有。

引用

  1. Ward-Caviness CK, Xu T, Aspelund T, et al. Improvement of myocardial infarction risk prediction via inflammation-associated metabolite biomarkers. Heart. 2017. PMID: 28255100. doi:10.1136/heartjnl-2016-310789

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。